Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Clinical trial NCT02089828 · UNKNOWN

Trial details

NCT number: NCT02089828
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Thromboangiitis Obliterans Arteritis Peripheral Arterial Disease

Start date: 2014-03-01
Primary completion: 2017-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.